Oxygenation predicts radiation response and survival in patients with cervix cancer.
OBJECTIVE
Hypoxia appears to be an important factor in predicting tumor relapse following radiation therapy. This study measured oxygenation prior to treatment in patients with cervix cancer using a polarographic oxygen electrode to determine if oxygenation was an important prognostic factor with regard to tumor control and survival.


METHODS
Between May 1994 and June 1997, 74 eligible patients with cervix cancer were entered into an ongoing prospective study of tumor oxygenation prior to primary radiation therapy. All patients were evaluated with an Eppendorf oxygen electrode during examination under anesthesia. Oxygenation data are presented as the hypoxic proportion, defined as the percentage of pO2 readings of <5 mm Hg (abbreviated as HP5).


RESULTS
The HP5 ranged from 2 to 99% with a median of 52%. With a median follow-up of 1.2 years, the disease-free survival (DFS) rate was 69% for patients with HP5 of < or =50% compared with 34% for those with HP5 of >50% (log-rank P = 0.02). Tumor size above and below the median of 5 cm was also significantly related to DFS (P = 0.0003) and patients with bulky hypoxic tumors had a significantly lower DFS (12% at 2 years) than either bulky oxygenated or non-bulky oxygenated or hypoxic tumors (65%, P = 0.0001).


CONCLUSIONS
Hypoxia and tumor size are significant adverse prognostic factors in a univariate analysis of disease-free survival in patients with cervix cancer. A high risk group of patients with bulky hypoxic tumors have a significantly higher probability of relapse and death.
Department of Radiation Oncology, Ontario Cancer Institute/Princess Margaret Hospital, University of Toronto, Canada.
A W
AW
Fyles
M
M
Milosevic
R
R
Wong
M C
MC
Kavanagh
M
M
Pintilie
A
A
Sun
W
W
Chapman
W
W
Levin
L
L
Manchul
T J
TJ
Keane
R P
RP
Hill
D000230:Adenocarcinoma / Q000378:metabolism / Q000532:radiotherapy; D000328:Adult; D000368:Aged; D000704:Analysis of Variance; D001918:Brachytherapy; D018196:Carcinoma, Adenosquamous / Q000378:metabolism / Q000532:radiotherapy; D002294:Carcinoma, Squamous Cell / Q000378:metabolism / Q000532:radiotherapy; D015687:Cell Hypoxia; D018572:Disease-Free Survival; D005260:Female; D005500:Follow-Up Studies; D005544:Forecasting; D006801:Humans; D017736:Ion-Selective Electrodes; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000473:pathology; D010100:Oxygen / Q000032:analysis; D010101:Oxygen Consumption; D011048:Polarography; D011379:Prognosis; D011446:Prospective Studies; D015996:Survival Rate; D016896:Treatment Outcome; D002583:Uterine Cervical Neoplasms / Q000378:metabolism / Q000473:pathology / Q000532:radiotherapy*
D010100:Oxygen